CRISPR Therapeutics AG - CRSP - stock price prediction, stock price target, analyst ratings from 27 analysts

CRISPR Therapeutics AG has a share price target of US$ 82, revenue growth forecast of -5.0%, and profit growth estimate of -47.2% for FY25, based on top 27 analyst calls.